China Meheco Group Co., Ltd.'s (SHSE:600056) Share Price Is Matching Sentiment Around Its Earnings

Simply Wall StJan 2 18:50 ET

Meheco Unit's Angina Tablets Passes Chinese Drug Regulator's Consistency Evaluation

MT NewswiresDec 23, 2024 01:40 ET

Meheco Unit's Sepsis Drug Included in China's Centralized Procurement Bid

MT NewswiresDec 16, 2024 00:01 ET

China Meheco Group (600056.SH): Sodium piperacillin for injection is expected to be selected for centralized procurement.

China Meheco Group (600056.SH) announced that on December 12, 2024, its subsidiary in Hainan...

Zhitong FinanceDec 13, 2024 06:13 ET

Meheco Receives Nod for Influenza Drug's Registration

MT NewswiresDec 5, 2024 01:41 ET

China Meheco Group (600056.SH): Subsidiary obtained pharmaceutical registration approval.

On December 4th, Gelonghui reported that China Meheco Group (600056.SH) announced that its wholly-owned subsidiary, Tianfang Pharmaceuticals Co., Ltd. (referred to as "Tianfang Pharmaceuticals"), received an approved pharmaceutical registration certificate from the National Medical Products Administration for a phosphor oseltamivir capsule (referred to as "the pharmaceutical"). Phosphor oseltamivir is a precursor drug of its active metabolite (oseltamivir carboxylate), which is a selective neuraminidase inhibitor for influenza viruses.

Gelonghui FinanceDec 4, 2024 03:48 ET